Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHSE1063-64 Mpox Vaccination and Gonorrhoea Vaccination

NHS England - North West · compiled

Tender information last checkedLast checked 30 Sept 2026, 07:02.

Opportunity overview

NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: NHSE NW • Lot 1 - Cheshire West & Chester • Lot 2 - Blackburn with Darwen • Lot 3 - Wirral NHSE GM • Lot 4 - Rochdale, Oldham, Bury • Lot 5 - Tameside, Stockport, Wigan • Lot 6 - Manchester, Trafford and Salford • Lot 7 - Bolton- MPOX

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

HCRG Care Services Limited

2 award entriesMatched by number
Contract value
£18.1
Awarded
Not supplied
Contract signed
28 Jul 2025
Status
active
Identifier
GB-COH 07557877
Location
Cheshire, UKD, WA7 4QX, United Kingdom
View 2 award IDs

046179-2025-Lot 1 - Cheshire West and Chester-1, 046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4

Brook Young People

Matched by number
Contract value
£18.1
Awarded
Not supplied
Contract signed
28 Jul 2025
Award ID
046179-2025-Lot 2 - Blackburn with Darwen-2
Status
active
Identifier
GB-COH 02466940
Location
Truro,, UKK3, TR1 2LH, United Kingdom
Contract value
£18.1
Awarded
Not supplied
Contract signed
28 Jul 2025
Award ID
046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5
Status
active
Identifier
GB-COH 07584906
Location
Liversedge, UKE4, WF15 6LP, United Kingdom
Contract value
£18.1
Awarded
Not supplied
Contract signed
28 Jul 2025
Award ID
046179-2025-Lot 6 - Manchester, Trafford and Salford-6
Status
active
Identifier
GB-NHS (R0A)
Location
MANCHESTER, UKD, M13 9W, United Kingdom
Contract value
£18.1
Awarded
Not supplied
Contract signed
3 Aug 2025
Award ID
046179-2025-Lot 7 - Bolton-7
Status
active
Identifier
GB-NHS (RMC)
Location
Bolton, UKD, BL4 0JR, United Kingdom

Classification

  • CPV85140000 — Miscellaneous health services

Lots

  • Lot 1 - Cheshire West and ChesterValue not stated
  • Lot 2 - Blackburn with DarwenValue not stated
  • Lot 3 - WirralValue not stated
  • Lot 4 - Rochdale, Oldham, BuryValue not stated
  • Lot 5 - Tameside, Stockport, WiganValue not stated
  • Lot 6 - Manchester, Trafford and SalfordValue not stated
  • Lot 7 - BoltonValue not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
NHSE1063-64
Status
complete
Procurement Method
limited
Main Procurement Category
services
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
The Relevant Authorities intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.

Covered By

GPA

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Id
85140000
Scheme
CPV
Description
Miscellaneous health services

Procedure reasons

Entry 1
Id
D_OUTSIDE_SCOPE
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Title
Lot 1 - Cheshire West and Chester
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 2
Id
2
Title
Lot 2 - Blackburn with Darwen
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 3
Id
3
Title
Lot 3 - Wirral
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 4
Id
4
Title
Lot 4 - Rochdale, Oldham, Bury
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 5
Id
5
Title
Lot 5 - Tameside, Stockport, Wigan
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 6
Id
6
Title
Lot 6 - Manchester, Trafford and Salford
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100
Entry 7
Id
7
Title
Lot 7 - Bolton
Status
cancelled
Has Options
No
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority

Award criteria

Criteria

Criterion 1
Name
Patient Choice
Type
quality
Description
100
Criterion 2
Name
Patient Choice
Type
cost
Description
100

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
Lot 1 - Cheshire West and Chester

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 2
Id
2
Related Lot
2

Delivery Location

Description
Lot 2 - Blackburn with Darwen

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 3
Id
3
Related Lot
3

Delivery Location

Description
Lot 3 - Wirral

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 4
Id
4
Related Lot
4

Delivery Location

Description
Lot 4 - Rochdale, Oldham, Bury

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 5
Id
5
Related Lot
5

Delivery Location

Description
Lot 5 - Tameside, Stockport, Wigan

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 6
Id
6
Related Lot
6

Delivery Location

Description
Lot 6 - Manchester, Trafford and Salford

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services
Item 7
Id
7
Related Lot
7

Delivery Location

Description
Lot 7 - Bolton

Delivery locations

Entry 1
Region
UKD

Additional Classifications

Entry 1
Id
85140000
Scheme
CPV
Description
Miscellaneous health services

Buyer, suppliers and contacts

Organisation 1
Id
GB-NHS-(Q75)
Name
NHS England - North West

Roles

buyer

Address

Region
UKD
Locality
Liverpool
Postal Code
L3 4BL
Country Name
United Kingdom
Street Address
Regatta Place, Brunswick Business Park, Summers Road

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Id
(Q75)
Scheme
GB-NHS
Legal Name
NHS England - North West

Contact

Organisation 2
Id
GB-NHS-(Q83)
Name
NHS England - North West Greater Manchester

Roles

buyer

Address

Region
UKD
Locality
MANCHESTER
Postal Code
M1 3BN
Country Name
United Kingdom
Street Address
4th floor Piccadilly place, London Road

Details

Identifier

Id
(Q83)
Scheme
GB-NHS
Legal Name
NHS England - North West Greater Manchester

Contact

Organisation 3
Id
GB-COH-07557877
Name
HCRG Care Services Limited

Roles

supplier

Address

Region
UKD
Locality
Cheshire
Postal Code
WA7 4QX
Country Name
United Kingdom
Street Address
The Heath Business & Technical Park, Runcorn

Details

Scale
large

Identifier

Id
07557877
Scheme
GB-COH
Legal Name
HCRG Care Services Limited
Organisation 4
Id
GB-COH-02466940
Name
Brook Young People

Roles

supplier

Address

Region
UKK3
Locality
Truro,
Postal Code
TR1 2LH
Country Name
United Kingdom
Street Address
Penhaligon House, Green Street,

Details

Scale
sme

Identifier

Id
02466940
Scheme
GB-COH
Legal Name
Brook Young People
Organisation 5
Id
GB-NHS-(RY7)
Name
Wirral Community Health and Care NHS Foundation Trust

Roles

supplier

Address

Region
UKD
Locality
Birkenhead
Postal Code
CH42 0LQ
Country Name
United Kingdom
Street Address
Derby Road

Details

Scale
large

Identifier

Id
(RY7)
Scheme
GB-NHS
Legal Name
Wirral Community Health and Care NHS Foundation Trust
Organisation 6
Id
GB-COH-07584906
Name
Locala Community Partnerships CIC

Roles

supplier

Address

Region
UKE4
Locality
Liversedge
Postal Code
WF15 6LP
Country Name
United Kingdom
Street Address
Eddercliffe Health Centre, Bradford Road,

Details

Scale
large

Identifier

Id
07584906
Scheme
GB-COH
Legal Name
Locala Community Partnerships CIC
Organisation 7
Id
GB-NHS-(R0A)
Name
Manchester University NHS Foundation Trust

Roles

supplier

Address

Region
UKD
Locality
MANCHESTER
Postal Code
M13 9W
Country Name
United Kingdom
Street Address
Cobbett House, Oxford Road

Details

Scale
large

Identifier

Id
(R0A)
Scheme
GB-NHS
Legal Name
Manchester University NHS Foundation Trust
Organisation 8
Id
GB-NHS-(RMC)
Name
Bolton NHS Foundation Trust

Roles

supplier

Address

Region
UKD
Locality
Bolton
Postal Code
BL4 0JR
Country Name
United Kingdom
Street Address
The Royal Bolton Hospital, Minerva Road, Farnworth

Details

Scale
large

Identifier

Id
(RMC)
Scheme
GB-NHS
Legal Name
Bolton NHS Foundation Trust
Organisation 9
Id
GB-FTS-157087
Name
NHS England - North West

Roles

reviewBody

Address

Locality
Liverpool
Postal Code
L3 4BL
Country Name
United Kingdom
Street Address
Regatta Place, Brunswick Business Park, Summers Road

Details

Identifier

Legal Name
NHS England - North West

Contact

Award information

Award 1
Id
046179-2025-Lot 1 - Cheshire West and Chester-1
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07557877
Name
HCRG Care Services Limited
Award 2
Id
046179-2025-Lot 2 - Blackburn with Darwen-2
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-02466940
Name
Brook Young People
Award 3
Id
046179-2025-Lot 3 - Wirral-3
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-NHS-(RY7)
Name
Wirral Community Health and Care NHS Foundation Trust
Award 4
Id
046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07557877
Name
HCRG Care Services Limited
Award 5
Id
046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-COH-07584906
Name
Locala Community Partnerships CIC
Award 6
Id
046179-2025-Lot 6 - Manchester, Trafford and Salford-6
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-NHS-(R0A)
Name
Manchester University NHS Foundation Trust
Award 7
Id
046179-2025-Lot 7 - Bolton-7
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active

Suppliers

Supplier 1
Id
GB-NHS-(RMC)
Name
Bolton NHS Foundation Trust

Contracts and changes

Entry 1
Id
046179-2025-Lot 1 - Cheshire West and Chester-1
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 1 - Cheshire West and Chester-1
Date Signed
29 Jul 2025, 00:00

Value

Amount
18.06
Currency
GBP
Entry 2
Id
046179-2025-Lot 2 - Blackburn with Darwen-2
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 2 - Blackburn with Darwen-2
Date Signed
29 Jul 2025, 00:00

Value

Amount
18.06
Currency
GBP
Entry 3
Id
046179-2025-Lot 3 - Wirral-3
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 3 - Wirral-3
Date Signed
29 Jul 2025, 00:00

Value

Amount
18.06
Currency
GBP
Entry 4
Id
046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4
Date Signed
29 Jul 2025, 00:00

Value

Amount
18.06
Currency
GBP
Entry 5
Id
046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5
Date Signed
29 Jul 2025, 00:00

Value

Amount
18.06
Currency
GBP
Entry 6
Id
046179-2025-Lot 6 - Manchester, Trafford and Salford-6
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 6 - Manchester, Trafford and Salford-6
Date Signed
29 Jul 2025, 00:00

Value

Amount
18.06
Currency
GBP
Entry 7
Id
046179-2025-Lot 7 - Bolton-7
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Status
active
Award ID
046179-2025-Lot 7 - Bolton-7
Date Signed
4 Aug 2025, 00:00

Value

Amount
18.06
Currency
GBP

Recorded locations

  • Buyer location · Liverpool · UKD · L3 4BL · United Kingdom
  • Delivery location · UKD

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-0581a5-2025-08-05T14:33:54+01:00compiled ·